Veraxa Biotech AG Stock: price and insider trades · United States
1 insider bought €8,646 of shares over the last 90 days, the latest by Hosseinion Warren, filed 29 Sept 2026.
Veraxa Biotech AG: what insiders have been doing
Veraxa Biotech AG has a thin disclosure history in our data (latest filing: 29 September 2026). New filings will appear here as soon as they are published. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 6,024 shares@ US$1.67100.0% of flowOrdinary SharesSEC:0001829126-26-010557:0Canonical exit: 9 Dec 2026 (T+90)
1 of 1 declaration
About Veraxa Biotech AG
Veraxa Biotech AG is a biotechnology company listed on NASDAQ, specializing in the development of innovative solutions for the healthcare sector. It focuses on the research and commercialization of biological treatments.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
